Menlo Therapeutics filed on Thursday with the SEC to raise up to $98M in an IPO. Source: BioSpace

ANI Phamaceuticals funded the acquisitions through a combination of cash and debt. Source: BioSpace

A look at a few biotechs which should outperform the market in 2018: Source: BioSpace

The parts expect the closing in the first quarter 2018. Source: BioSpace

The company's sales department will take the brunt of the layoffs, losing 235 jobs. Source: BioSpace

Celgene announced back in October that it was discontinuing its GED-0301 program for Crohn's disease and now that decision is costing the company $411M. Source: BioSpace

The J.P. Morgan Healthcare Conference is held every year in early January, and this year it will be Jan. 8-11 in San Francisco, as usual. Source: BioSpace

Thanks to the Republican tax legislation, pharmaceutical stocks are set to continue their heady northward trajectory in 2018. Source: BioSpace

The drug showed a significant, clinically meaningful and fast-acting improvement in depression symptoms compared to an intranasal placebo. Source: BioSpace

The drugmaker intends to expand development of therapeutic antibodies at the lab. Source: BioSpace